BioLargo, Inc. (BLGO)
OTCMKTS · Delayed Price · Currency is USD
0.1850
-0.0050 (-2.63%)
Jan 23, 2026, 3:02 PM EST
BioLargo Revenue
BioLargo had revenue of $1.10M in the quarter ending September 30, 2025, a decrease of -74.65%. This brings the company's revenue in the last twelve months to $10.81M, down -41.57% year-over-year. In the year 2024, BioLargo had annual revenue of $17.78M with 45.37% growth.
Revenue (ttm)
10.81M
Revenue Growth
-41.57%
P/S Ratio
5.41
Revenue / Employee
257.26K
Employees
42
Market Cap
58.43M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17.78M | 5.55M | 45.37% |
| Dec 31, 2023 | 12.23M | 6.35M | 107.85% |
| Dec 31, 2022 | 5.88M | 3.35M | 132.48% |
| Dec 31, 2021 | 2.53M | 99.00K | 4.07% |
| Dec 31, 2020 | 2.43M | 571.00K | 30.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cardinal Ethanol, LLC | 350.34M |
| NuEarth | 15.34M |
| Vulcan International | 5.35M |
| Lithium & Boron Technology | 2.47M |
| Reflectkote | 2.06M |
| American Green Group | 688.17K |
| Angstrom Technologies | 642.35K |
| Energy and Environmental Services | 314.71K |
BioLargo News
- 7 days ago - BioLargo to Present at Sidoti's Micro-Cap Virtual Conference on Thursday January 22nd at 1pm EST - Accesswire
- 25 days ago - BioLargo Reflects on 2025 Progress and Positions for the Next Phase of Global Infrastructure, Environmental, and Medical Innovation - Accesswire
- 7 weeks ago - BioLargo Subsidiary BEST Featured in Chemical Engineering Magazine for PFAS Breakthrough - Accesswire
- 2 months ago - BioLargo to Present at NobleCon's 21st Annual Emerging Growth Equity Conference, Dec. 2-3, 2025 - Newsfile Corp
- 2 months ago - BioLargo Reports Q3 2025 Operating and Financial Results - Accesswire
- 2 months ago - BioLargo, Inc. (BLGO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - BioLargo Q3 2025 Earnings Results Webcast and Conference Call on Friday, November 14th, 2025 - 4:30 PM Eastern Time - Accesswire
- 2 months ago - BioLargo Subsidiary Clyra Medical Technologies Forms Strategic Alliance with Advanced Solution to Launch ViaCLYR(TM) Wound Irrigation Solution Nationwide - Accesswire